ViaDerma (ViaDerma) Debt-to-Asset : 0.16 (As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Debt-to-Asset?

ViaDerma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2012 was $4.42 Mil. ViaDerma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2012 was $2.86 Mil. ViaDerma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2012 was $45.83 Mil. ViaDerma's debt to asset for the quarter that ended in Jun. 2012 was 0.16.

ViaDerma Debt-to-Asset Historical Data

The historical data trend for ViaDerma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Debt-to-Asset Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Debt-to-Asset

0.13

0.11

0.13

0.18

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
Debt-to-Asset	Get a 7-Day Free Trial															0.11	0.20	0.18	0.17	0.16

Competitive Comparison of ViaDerma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where ViaDerma's Debt-to-Asset falls into.

ViaDerma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

ViaDerma's Debt-to-Asset for the fiscal year that ended in Dec. 2011 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.356	+	3.32)	/	42.645
	=	0.18

ViaDerma's Debt-to-Asset for the quarter that ended in Jun. 2012 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.42	+	2.862)	/	45.832
	=	0.16

ViaDerma (OTCPK:VDRM) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

ViaDerma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of ViaDerma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.